Role of mitochondria in quercetin-enhanced chemotherapeutic response in human non-small cell lung carcinoma H-520 cells

Anticancer Research

Volumn 26, Issue 2 A, 2006, Pages 1297-1303

  Kuhar, Meenakshi ^a   Sen, Sudip ^a   Singh, Neeta ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Apoptosis; Cisplatin; Lung carcinoma; Mitochondria; Quercetin

Indexed keywords

ALLOGRAFT INFLAMMATORY FACTOR 1; CISPLATIN; CYTOCHROME C; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL; QUERCETIN;

APOPTOSIS; ARTICLE; CANCER CELL; CANCER PREVENTION; CELL VIABILITY; CHEMOPROPHYLAXIS; DRUG ACTIVITY; DRUG EFFECT; DRUG MECHANISM; DRUG SAFETY; ENZYME REGULATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TREATMENT RESPONSE;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; APOPTOSIS; APOPTOSIS INDUCING FACTOR; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL NUCLEUS; CISPLATIN; CYTOCHROMES C; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; QUERCETIN; UP-REGULATION;

EID: 33645809159     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Wang G, Reed E and Li QQ: Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer. Oncol Rep 5: 955-965, 2004.
2. Govindan R and Garfield DH: Treatment approaches in patients with advanced non-small cell lung cancer and poor performance status. Semin Oncol 31: 27-31, 2004.
3. Seve P and Dumontet C: Chemoresistance in non-small cell lung cancer. Curr Med Chem Anti Cane Agents 5: 73-88, 2005.
4. Caltagirone S, Rossi C, Poggi A, Ranelletti FO, Natali PG, Brunetti M, Aiello FB and Piantelli M: Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. Int J Cancer 87: 595-600, 2000.
5. Schwarz D, Kisselev P and Roots I: CYP1A1 genotype-selective inhibition of benzo[α]pyrene activation by quercetin. Eur J Cancer 41: 151-158, 2005.
6. Dragnev KH, Petty WJ, Ma Y, Rigas JR and Dmitrovsky E: Nonclassical retinoids and lung carcinogenesis. Clin Lung Cancer 6: 237-244, 2005.
7. Kalemkerian GP and Ou X: Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines. Cancer Chemother Pharmacol 43: 145-150, 1999.
8. Wang G-Q, Gastman BR, Wieckowski E, Goldstein LA, Gambotto A, Kim T-H, Fang B, Rabinovitz A, Yin X-M and Rabinowich H: A role for mitochondrial bak in apoptotic response to anticancer drugs. J Biol Chem 276: 34307-34317, 2001.
9. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
10. Sharma H, Sen S, Mathur M, Bahadur S and Singh N: Combined evaluation of expression of telomerase, survivin, and anti-apoptotic Bcl-2 family members in relation to loss of differentiation and apoptosis in human head and neck cancers. Head Neck 8: 733-740, 2004.
11. Khanna N, Reddy VG, Tuteja N and Singh N: Differential gene expression in apoptosis: identification of ribosomal protein S29 as an apoptotic inducer. Biochem Biophys Res Commun 277: 476-486, 2000.
12. Sharma H, Sen S, Muzio LL, Mariggio A and Singh N: Antisense-mediated downregulation of anti-apoptotic proteins induces apoptosis and sensitizes head and neck squamous cell carcinoma cells to chemotherapy. Cancer Biol Ther 4: 720-727, 2005.
13. Sen S, Sharma H and Singh N: Curcumin enhances Vinorelbine mediated apoptosis in NSCLC cells by the mitochondrial pathway. Biochem Biophys Res Commun 331: 1245-1252, 2005.
14. Manson MM, Farmer PB, Gescher A and Stewad WP: Innovative agents in cancer prevention. Rec Results Cancer Res 166: 257-275, 2005.
15. Sarkar FH and Li Y: Cell signaling pathways altered by natural chemopreventive agents. Mutat Res 555: 53-64, 2004.
16. Boise LH, Gonzalez-Garcia M, Postema CE, Ding L, Lindsten T, Turka LA, Mao X, Nunez G and Thompson CB: Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 74: 597-608, 1993.
17. Jie Yang, Jones DP et al: Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science 275: 1129-1132, 1997.
18. Fisher TC, Milner AE, Gregory CD, Jackman AL, Aherne GW, Hartley JA, Dive C and Hickman JA: Bcl-2 modulation of apoptosis induced by anticancer drugs: resistance to thymidylate stress is independent of classical resistance pathways. Cancer Res 53: 3321-3326, 1993.
19. Nguyen TT, Tran E, Nguyen TH, Do PT, Huynh TH and Huynh H: The role of activated MEK-ERK pathway in quercetin-induced growth inhibition and apoptosis in A549 lung cancer cells. Carcinogenesis 25: 647-659, 2004.
20. Susin SS, Zamzami N, Kroemer G et al: Bcl-2 inhibits the mitochondrial release of an apoptogenic protease. J Exp Med 184: 1331-1341, 1996.
21. Wang IK, Lin-Shiau SY and Lin JK: Induction of apoptosis by apigenin and related flavonoids through cytochrome c release and activation of caspase-9 and caspase-3 in leukaemia HL-60 cells. Eur J Cancer 35: 1517-1525, 1999.